| First Choice Hospice 1371 West 1250 South, Orem, UT, 84058 | |
| (801) 434-4100 |
News Archive
The federal government sent a brochure to more than 40 million Medicare beneficiaries, "Medicare and the New Health Care Law - What It Means for You," which is generating political controversy.
A major milestone was reached when nusinersen, an investigational treatment for spinal muscular atrophy (SMA), was shown to significantly improve achievement of motor milestones in babies with infantile-onset SMA, according to an interim analysis of the double-blind, randomized, placebo controlled Phase 3 clinical trial called ENDEAR.
JDRF and the Centre for Global eHealth Innovation at the University Health Network in Toronto announced publication of interoperability standards for diabetes devices. The work is the result of JDRF Canadian Clinical Trial Network funding to Dr. Joseph Cafazzo at UHN to pilot the development of standard communication protocols that define how diabetes devices, such as insulin pumps, blood glucose meters, and continuous glucose monitors, communicate with one another and with other devices.
House Speaker John Boehner, R-Ohio, has scheduled a Friday vote on the proposal, which some news outlets describe as a "bitter pill" for Democrats.
› Verified 5 days ago
| Name | First Choice Hospice |
|---|---|
| Location | 1371 West 1250 South, Orem, Utah |
| Hospice ID | 461549 |
| Category | Freestanding Hospice |
| Ownership Type | Proprietary - Corporation |
| Profit Type | FOR PROFIT |
| SSA county code | 240 |
News Archive
The federal government sent a brochure to more than 40 million Medicare beneficiaries, "Medicare and the New Health Care Law - What It Means for You," which is generating political controversy.
A major milestone was reached when nusinersen, an investigational treatment for spinal muscular atrophy (SMA), was shown to significantly improve achievement of motor milestones in babies with infantile-onset SMA, according to an interim analysis of the double-blind, randomized, placebo controlled Phase 3 clinical trial called ENDEAR.
JDRF and the Centre for Global eHealth Innovation at the University Health Network in Toronto announced publication of interoperability standards for diabetes devices. The work is the result of JDRF Canadian Clinical Trial Network funding to Dr. Joseph Cafazzo at UHN to pilot the development of standard communication protocols that define how diabetes devices, such as insulin pumps, blood glucose meters, and continuous glucose monitors, communicate with one another and with other devices.
House Speaker John Boehner, R-Ohio, has scheduled a Friday vote on the proposal, which some news outlets describe as a "bitter pill" for Democrats.
› Verified 5 days ago
| NPI Number | 1083622187 |
| Organization Name | First Choice Home Health & Hospice Specialists, Inc. |
| Address | 1365 W 1250 S Orem, Utah, 84058 |
| Phone Number | (801)434-4100 |
News Archive
The federal government sent a brochure to more than 40 million Medicare beneficiaries, "Medicare and the New Health Care Law - What It Means for You," which is generating political controversy.
A major milestone was reached when nusinersen, an investigational treatment for spinal muscular atrophy (SMA), was shown to significantly improve achievement of motor milestones in babies with infantile-onset SMA, according to an interim analysis of the double-blind, randomized, placebo controlled Phase 3 clinical trial called ENDEAR.
JDRF and the Centre for Global eHealth Innovation at the University Health Network in Toronto announced publication of interoperability standards for diabetes devices. The work is the result of JDRF Canadian Clinical Trial Network funding to Dr. Joseph Cafazzo at UHN to pilot the development of standard communication protocols that define how diabetes devices, such as insulin pumps, blood glucose meters, and continuous glucose monitors, communicate with one another and with other devices.
House Speaker John Boehner, R-Ohio, has scheduled a Friday vote on the proposal, which some news outlets describe as a "bitter pill" for Democrats.
› Verified 5 days ago
| Quality Measure | Provider Score | National Score |
|---|---|---|
| Patients or caregivers who were asked about treatment preferences like hospitalization and resuscitation at the beginning of hospice care | 100.0 | 98.3 |
| Patients or caregivers who were asked about their beliefs and values at the beginning of hospice care | 100.0 | 93.6 |
| Patients who were checked for pain at the beginning of hospice care | 99.3 | 93.9 |
| Patients who got a timely and thorough pain assessment when pain was identified as a problem | 42.9 | 77.7 |
| Patients who were checked for shortness of breath at the beginning of hospice care | 100.0 | 97.3 |
| Patients who got timely treatment for shortness of breath | 100.0 | 94.6 |
| Patients taking opioid pain medication who were offered care for constipation | 100.0 | 93.3 |
News Archive
The federal government sent a brochure to more than 40 million Medicare beneficiaries, "Medicare and the New Health Care Law - What It Means for You," which is generating political controversy.
A major milestone was reached when nusinersen, an investigational treatment for spinal muscular atrophy (SMA), was shown to significantly improve achievement of motor milestones in babies with infantile-onset SMA, according to an interim analysis of the double-blind, randomized, placebo controlled Phase 3 clinical trial called ENDEAR.
JDRF and the Centre for Global eHealth Innovation at the University Health Network in Toronto announced publication of interoperability standards for diabetes devices. The work is the result of JDRF Canadian Clinical Trial Network funding to Dr. Joseph Cafazzo at UHN to pilot the development of standard communication protocols that define how diabetes devices, such as insulin pumps, blood glucose meters, and continuous glucose monitors, communicate with one another and with other devices.
House Speaker John Boehner, R-Ohio, has scheduled a Friday vote on the proposal, which some news outlets describe as a "bitter pill" for Democrats.
› Verified 5 days ago
| Home Health Aides | 13.5 |
| Licensed Practical or Vocational Nurses | 2 |
| Medical Social Workers | 3 |
| Physicians | 1 |
| Registered Nurses | 9.75 |
| Other Personnel | 5 |
| Total Employees | 34.25 |
|---|
News Archive
The federal government sent a brochure to more than 40 million Medicare beneficiaries, "Medicare and the New Health Care Law - What It Means for You," which is generating political controversy.
A major milestone was reached when nusinersen, an investigational treatment for spinal muscular atrophy (SMA), was shown to significantly improve achievement of motor milestones in babies with infantile-onset SMA, according to an interim analysis of the double-blind, randomized, placebo controlled Phase 3 clinical trial called ENDEAR.
JDRF and the Centre for Global eHealth Innovation at the University Health Network in Toronto announced publication of interoperability standards for diabetes devices. The work is the result of JDRF Canadian Clinical Trial Network funding to Dr. Joseph Cafazzo at UHN to pilot the development of standard communication protocols that define how diabetes devices, such as insulin pumps, blood glucose meters, and continuous glucose monitors, communicate with one another and with other devices.
House Speaker John Boehner, R-Ohio, has scheduled a Friday vote on the proposal, which some news outlets describe as a "bitter pill" for Democrats.
› Verified 5 days ago
| A-plus Hospice Location: 1443 North 1200 West, Orem, Utah, 84057 Phone: (801) 434-4100 |
| First Choice Hospice Location: 1371 West 1250 South, Orem, Utah, 84058 Phone: (801) 434-4100 |
| Alpha Omega Hospice Llc Location: 257 South Orem Blvd, Orem, Utah, 84058 Phone: (801) 434-4100 |
| 5 Star Hospice Llc Location: 758 South 400 East, Orem, Utah, 84097 Phone: (801) 434-4100 |